Herbert Loong, Clinical Associate Professor at The Chinese University of Hong Kong, shared a post on X:
“Our PhD candidate Han Fei updated group on his ongoing project on molecular subclassification and predictive biomarkers to stratify for immunotherapy sensitivity in leiomyosarcomas during postgraduate students’ seminar earlier this week.”
